We have previously shown that hepatic lipase (HL) is inactive when bound to purified heparan sulfate proteoglycans and can be liberated by HDL and apolipoproteinA-I (apoA-I), but not by LDL or VLDL. In this study, we show that HDL is also able to displace HL directly from the surface of the hepatoma cell line, HepG2, and Chinese Hamster Ovary cells stably overexpressing human HL. ApoA-I is more efficient at displacing cell surface HL than is HDL and different HDL classes vary in their ability to displace HL from the cell surface. HDL 2 have a greater capacity to remove HL from the cell surface and intracellular compartments as compared to the smaller HDL particles. The different HDL subclasses also uniquely affect the activity of the enzyme. HDL 2 stimulates HL mediated hydrolysis of VLDL-TG, while HDL 3 is inhibitory.
Introduction
Human hepatic lipase (HL) is a 64 kDa glycoprotein anchored by heparan sulfate proteoglycans (HSPG) to the surface of endothelial cells and hepatocytes (1) . HL functions both as a cell surface ligand for lipoprotein uptake and as a lipolytic enzyme that mediates the clearance of TG from the blood stream and the conversion of VLDL to LDL (2) (3) (4) (5) (6) (7) (8) (9) . It has been known for over five decades that displacement of lipolytic enzymes from cell surface binding sites with heparin results in rapid hydrolysis of TG-rich lipoproteins in lipemic serum (10, 11) . However, it is still commonly believed that both HL and LPL are catalytically active when bound to cell surface proteoglycans and that this association may indeed enhance the lipolysis of TG (reviewed in (12) ).
This common view is in fact counter-intuitive to the interfacial catalytic models proposed for lipases, which have shown a clear requirement for enzyme hopping or shuttling between substrates for optimal hydrolysis (13, 14) . In agreement with this view, we showed that HL is active only when it is free in solution and indeed completely inactive when bound to pure HSPG (15) . In addition we showed that HL could be displaced from a pure HSPG matrix by HDL, and specifically by apolipoproteinA-I (apoA-I), but not by LDL and VLDL. In the present study, we have re-evaluated this displacement phenomenon in HepG2 cells and in a Chinese Hamster Ovary cell line stably overexpressing human HL (CHO-hHL). As with our pure HSPG studies, we show that only apoA-I and HDL are able to displace cell surface HL. We further show that different HDL classes vary in their ability to displace HL and demonstrate that the lowest density fractions (HDL 2 ) have the greatest capacity to remove HL from the cell surface and intracellular compartments.
In addition to its ability to displace cell surface HL, we have previously reported that apoA-I and HDL directly affect HL mediated TG hydrolysis and showed that the rate of TG hydrolysis is regulated by the amount of HDL in plasma (15) . This observation suggests that pre and post heparin HL activities are a function of a direct effect of apoA-I and HDL on the enzyme activity, in addition to the amount of circulating enzyme. We have extended this previous work and now show that HL mediated TG hydrolysis is also a function of the kind of HDL in plasma.
While the total HDL fraction is inhibitory to HL, the component HDL fractions affect HL quite differently. We find that the smaller HDL 3 are inhibitory to VLDL hydrolysis, while the larger and more buoyant HDL 2 are conversely, quite stimulatory. Modulation of HL activity is therefore related to the lipidation and interfacial properties of the particles. In addition, we show that in contrast to our earlier hypothesis, inhibition of VLDL hydrolysis is not caused by apoA-I transfer to the lipoprotein surface, but appears to result from alterations in the interlipoprotein shuttling of HL between VLDL and the different HDL particles.
In this study, we demonstrate that HDL regulates both the displacement of HL from cell surface HSPG and also the hydrolysis of VLDL-TG. HDL speciation appears to play an important role in both the clearance of plasma TG and the catabolism of VLDL.
Experimental Procedures
Materials. Free fatty acid diagnostic kits were purchased from Roche Diagnostics (Laval, PQ). Novex polyacrylamide gels, Ham's F12 medium, Geneticin® Selective Antibiotic (G418 sulfate), Eagle's Minimal Essential Medium (EMEM), L-glutamine and penicillin/streptomycin Hepatic lipase purification. HL was purified from post heparin human plasma by heparin affinity chromatography as described by Ehnholm et al. (16) . Briefly, post heparin human plasma was collected from normolipidemic subjects and a 20% TG emulsion (Intralipid 20%, Baxter Corp.
Toronto, ON) was added to the plasma. Lipid cakes were harvested centrifugally and delipidated.
The aqueous solution of crude HL was then loaded onto a Heparin Sepharose CL-6B column and eluted with a salt gradient of 0.15 M to 1.50 M NaCl in 5 mM sodium barbital, pH 7.4, 20% glycerol. The HL fractions were pooled and stored at -80ºC until required.
HL activity was characterized using a [ 3 H]-TG emulsion and quantified into units (U) of enzyme activity (where 1 U = 1 µmol fatty acid hydrolyzed/h). The protein concentration of the purified HL was 0.114 mg/ml and the specific activity of the isolated HL was determined to be 19,455 U/mg protein. The isolated HL was further characterized by SDS-PAGE (12%) and immunoblotting using the anti-HL mAb. A single band with an apparent molecular mass of 66 kDa was evident.
Isolation of lipoproteins.
Plasma from fasting, normolipidemic subjects were collected. VLDL and HDL were isolated by sequential ultracentrifugation (17) within the density ranges Á<1.006 and Á =1.063-1.250 g/ml, respectively. The protein content was determined by the Lowry method as modified by Markwell et al. (18) and TG content was determined enzymatically using diagnostic kits (Roche Diagnostics, Laval, Québec).
Isolation of HDL subfractions by density gradient ultracentrifugation. Plasma from fasting, normolipidemic subjects were collected and HDL subfractions were isolated by KBr discontinuous gradient ultracentrifugation following an initial HDL (ρ=1.063-1.25) isolation from plasma by sequential ultracentrifugation. Briefly, 50 mg of sucrose was added to the HDL isolated by KBr discontinuous gradient ultracentrifugation. Using the underlay method 12.33 ml of a 1mM EDTA containing 0.02% NaN 3 was added to an open top centrifugation tube followed by 10 ml of 1.080 g/ml density solution, then 6.67 ml of a 1.210 g/ml density solution and finally 10 ml of HDL/KBr/sucrose mix. The HDL was centrifuged at 27 500 rpm for 22hr at 8 o C in the SW28 rotor in a Beckman ultracentrifuge. Following centrifugation, the upper 14ml were discarded and 12-2ml fractions ranging in densities from 1.063 to 1.27 were obtained and dialyzed against PBS pH 7.2 without EDTA or NaN 3 . The densities of the HDL fractions were determined by refractometry.
Quantification of hepatic lipase in CHO-hHL and HepG2 cells. CHO-hHL were plated in Hams F12 medium containing 10% FBS and 500 ¼g/ml G418 (plating medium) and following attachment, the medium was changed to Hams F12 medium containing 1% FBS and 500 ¼g/ml G418 (complete medium). HepG2 cells were plated and grown to confluence in EMEM containing 10% FBS, 2% L-Glutamine and 1% pen/strep (complete medium). After an overnight incubation with serum free media, the cells were washed and incubated with serum free medium ± apoAI or HDL at 37ÚC for the various times. Following removal of the medium, the cells were washed with PBS and incubated with 60µl of SDS sample buffer (62.5 mM Tris-HCl, pH 6.8, 20% glycerol, 2% SDS, 0.5% (w/v) bromophenol blue) overnight at room temperature. The solubilized extract was subjected to electrophoresis on an To differentiate intracellular from matrix bound HL, the cells were washed and incubated with medium (in the absence of FBS) containing cytochalasin B at a final concentration of 10 ¼g/ml for 1h at 37 o C. Plates were then placed on ice and cells were subjected to repeat aspiration of the medium to remove the cell monolayer. This process was repeated with three washes of PBS. The cells and wash buffer were centrifuged at 1300 rpm for 10 min at 8 o C in the Sorvall RT 6000D low speed centrifuge. The supernatant was removed and the pellet was solubilized in 60µl of SDS sample buffer. The extracellular matrix (ECM), which remained on the plate, was also solubilized in 60 µl of SDS sample buffer. The solubilized pellet and the ECM were electrophoresed, transferred to a nitrocellulose membrane and the HL content was analyzed by Western blot analysis as detailed above. The membranes were exposed to film for various times and HL content was quantified by densitometry.
Determination of hepatic lipase activity in CHO-hHL and HepG2 cells medium. CHO-hHL and
HepG2 cells were grown to confluence. After an overnight incubation with serum free media, the cells were washed and incubated with serum free medium ± HDL or heparin at 37ÚC for various times. 150 µl of the medium was removed from the cells and the HL activity was determined using a [ 3 H]-TG emulsion as previously described (16 Purification of apoA-I and preparation of spherical LpA-I complexes. ApoA-I was isolated by size exclusion chromatography on a Sephacryl S-200 HR column (19) . Prior to use, the apoA-I was resolubilized in 6M guanidine HCl, 10mM Tris, pH 7.2, and dialyzed extensively against PBS pH 7.2. Reconstituted LpA-I complexes were prepared by co-sonicating POPC and apoA-I (molar ratios indicated in figure 6) as previously described (20) . Briefly, specific amounts of lipids in chloroform were dried under nitrogen in a 12 x 75 mm test tube. 800 µl of PBS was added and the lipid-PBS mixture was successively sonicated under nitrogen for 1 min at constant output, incubated at 37°C for 30 min and sonicated again for 5 min at 95% duty cycle. ApoA-I (2 mg of a 1.4 mg protein/ml PBS solution) was added to the lipid mixture and co-sonicated for 4 x 1 min at 90% duty cycle with 1 min cooling periods between sonications. respectively. Incubations were carried out for 30 min and the reactions were terminated on ice.
The total amount of fatty acid released during the incubation was determined using free fatty acid diagnostic kits.
Results

Characterization of hepatic lipase in CHO-hHL and HepG2 cells. Previous reports from
this laboratory showed that HL can be displaced from pure HSPG by HDL and apoA-I (15). In order to extend these studies to a cell culture system, CHO-hHL and HepG2 cells were characterized and then utilized to explore the ability of HL to be displaced from the cell surface.
CHO-hHL and HepG2 cells were grown to confluence in complete medium and the adherent cells were either extracted with SDS sample buffer to produce whole cell lysates or treated with cytochalasin B to separate the intact cells from their ECM (21) and allow differentiation of both intracellular and cell surface HL. Whole cell lysates, ECM and cell extracts were individually treated with SDS sample buffer, and then electrophoresed and probed for HL. Results showed that HL from whole cell lysates of both cell lines exhibits two distinct bands, one at 66 kDa and the other at 52 kDa, which appear to represent two differently glycosylated forms of the enzyme.
The HL associated with the cell surface ECM is similar in size to that of purified, human HL obtained from post heparin human plasma and has an apparent molecular mass of 66 kDa. The HL present in the cell extract appears to be an intracellular form that is smaller and has an apparent molecular mass of 52 kDa (data not shown). 
Displacement of HL from CHO-hHL and
Effect of HDL subfractions on VLDL hydrolysis.
To determine whether the HDL fractions differed in their ability to affect the hydrolysis of VLDL by HL, co-incubation hydrolytic assays were performed. The results in figure 4 show the relative total lipid hydrolytic rates for VLDL ± HDL or apoA-I and are expressed as percent of hydrolysis of VLDL alone.
The figure shows that HDL density has significant effects, both stimulatory and inhibitory, on HL mediated VLDL hydrolysis. As the density of the HDL increases, progressively less stimulation and more inhibition of HL mediated VLDL hydrolysis can be observed. While the most buoyant HDL fraction (p=1.11) was found to stimulate HL activity by ~30%, the more dense HDL fractions (p=1.19) inhibited the enzyme's activity by up to 50 %. As previously shown, apoA-I inhibits HL mediated VLDL hydrolysis by 80-90 %. The data therefore suggests that HDL composition plays a role in determining whether HDL stimulates or inhibits HL mediated VLDL hydrolysis.
HDL subfractions and apoA-I transfer to VLDL.
To determine whether the ability of HDL to either stimulate or inhibit VLDL lipolysis is related to binding of apoA-I to VLDL, solid phase radio-immunometric assays were performed. VLDL that had been previously incubated for 3h with HL ± HDL or apoA-I were added to Removawells coated with a mAb to apoB (1D1). ApoA-I association with the VLDL was then measured with a pooled mixture of two 125 I-labeled mAbs to apoA-I (4H1 and 5H6). As can be seen from figure 5, significant amounts of apoA-I could be found associated with the VLDL that had been incubated with either apoA-I or the different HDL fractions, but not with the native VLDL. The inset shows that an inverse relationship exists between HDL density and apoA-I transfer to VLDL. As the HDL density increased (towards the small VHDL), there was progressively less apoA-I transferred to the VLDL. It is also of note that similar amounts of apoA-I were transferred to VLDL in incubations with pure apoA-I or the d=1.100 g/l HDL density fraction (HDL 2 ) and yet, apoA-I is inhibitory to HL and the less dense HDL are stimulatory.
Effect of apoA-I lipidation on VLDL hydrolysis. In order to determine whether the stimulatory/inhibitory effects seen with the HDL fractions were related to the particle physical properties, hydrolytic assays were performed to evaluate the effect of apoA-I lipidation on VLDL hydrolysis. Figure 6 shows that the amount of phospholipid associated with apoA-I directly affects its ability to both stimulate and inhibit HL. Addition of a few molecules of phospholipid to apoA-I (POPC:apoA-I (mol:mol) 5:1) converted the apoprotein from an inhibitor of HL, to a stimulator. However, while the poorly-lipidated Lp1A-I complex profoundly stimulated HL mediated VLDL hydrolysis, additional lipidation of apoA-I reduced this stimulatory effect. The 35:1 Lp2A-I complex stimulated HL to a much lesser extent than the 5:1 particle and the 60:1 Lp2A-I complex actually inhibited the enzyme activity by almost 50 %. This therefore suggests that the lipidation-dependent physical properties of HDL may affect its ability to regulate HL.
Discussion
HL is anchored by HSPG to the surfaces of liver sinusoidal endothelial cells and hepatocytes (1) . Early studies (22) (23) (24) identified HL as a triglyceride lipase activity that was not detectable in regular plasma samples, but was present in post heparin plasma and in heparin perfusates of the liver. It is now well established that when HL and LPL are released from cell surface HSPG by heparin administration, TG hydrolysis and clearance from the blood stream is increased (11, 25) . This suggests that these enzymes are less active when bound to the cell surface and is consistent with our previous work showing that VLDL hydrolysis by HL is significantly inhibited when HL is bound to pure HSPG (15) . The data also suggest that efficient lipolysis requires displacement of HL from the cell surface matrix and the factors that regulate displacement may therefore be critical to achieve rapid TG hydrolysis.
We have further evaluated the factors that regulate HL displacement in 2 different cell lines; HepG2 cells that endogenously express HL and a CHO cell line stably overexpressing human HL. We chose to study displacement in a CHO cell culture model in which human HL was under control of a foreign gene promoter (cytomegalovirus) to circumvent any possible gene regulatory affects of lipoproteins or apoA-I and consequential changes in the production and secretion of the expressed protein. Western blots showed that the CHO-hHL extracts exhibit 2 immunoreactive HL proteins, one that represents the full sized HL molecule and is associated with the cell surface matrix and a second, lower molecular mass intracellular species. This smaller intracellular HL protein appears to be a less glycosylated form of the enzyme similar to that observed by others (26) . We showed that both apoA-I and HDL are able to readily displace cell surface HL and that, as with the pure HSPG displacement studies, apoA-I is >2-fold more able to displace surface HL than is HDL. Experiments in HepG2 cells had almost identical results, which suggest that HDL predominantly acts by a displacement of the surface enzyme and may have less effect on the regulation of the HL gene. Displacement of cell surface HL was further shown to be concomitant with the liberation of an active enzyme and increased lipid hydrolysis.
HL displacement was shown to also parallel decreases in intracellular HL levels. This suggests that apoA-I mediated HL displacement from the cell surface is more rapid than its replenishment by the newly synthesized and secreted HL. It also suggests that the displaced HL remains tightly bound to the (lipoprotein) components in the medium and does not re-associate with the cell surface.
We showed that the lowest density HDL fractions have the greatest capacity to remove HL from both the cell surface and intracellular compartments. It is striking that almost the entire cell surface and a significant amount of the intracellular HL is removed from the CHO-hHL cell line after 1 h incubation with an HDL 2 fraction. The depletion appeared to be an acute phenomenon, as both intracellular and cell surface HL were replenished after extended incubations (data not shown). In contrast to HDL 2 , the smaller, high density HDL fractions were much less able to displace HL. Since HL is readily displaced by lipid free apoA-I, the ability of HDL to displace HL from the cell surface may be a function of the amount of loosely-bound or exchangeable apoA-I on the surface of the larger HDL 2 particles. It has been previously reported that HDL 2 may allow for a greater dissociation of lipid-poor apoA-I than the smaller HDL particles (27, 28) and this is consistent with our VLDL-apoA-I association studies. Figure 5 shows that more apoA-I can be transferred to the VLDL surface from large and less dense HDL fractions than from the smaller particles.
This data suggests that higher levels of HDL 2 may promote a greater displacement of cell surface HL and enhanced TG hydrolysis by HL ( figure 7 ). This appears consistent with a number of studies that have show that there is an inverse relationship between the magnitude of post prandial lipemia and plasma levels of HDL 2 (29, 30) . However, the data does not appear consistent with reports that have identified an inverse relationship between plasma HDL 2 levels and post heparin HL activities (31, 32) . However, with this new view that HDL acts like heparin and displaces cell surface HL, it follows that if HDL 2 levels are high and HL is readily displaced from cell surface HSPG, lower amounts of HL may be liberated by heparin and this may result in reduced post heparin activities.
Consistent with this view, larger HDL fractions also appear to directly stimulate VLDL-TG hydrolysis by HL ( figure 7B) . Therefore, the well described inverse relationship between HDL 2 and post prandial lipemia may be due to both an enhanced liberation of HL into the plasma compartment and a direct stimulation in TG hydrolysis. Conversely, the smaller HDL fractions are much less able to liberate HL and actually inhibit HL activity. While it is known that the apoCs readily transfer between HDL and VLDL during lipolysis (33),(34), differences do not appear to be due to unique apoprotein effects as both stimulation and inhibition of HL could be demonstrated with different kinds of reconstituted HDL containing only apoA-I. Of note, the lipid poor rHDL were much more stimulatory of HL than the phospholipid enriched particles (figure 6). The most stimulatory of the recombinant particles was the 5:1 PC:apoA-I particle, a complex that we have previously shown to also be highly reactive with LCAT and similar in structure and charge to the preβ HDL subfractions described by others (35) . Previous studies by Barrans and Guendouzi have shown that HL has the ability to generate preβ HDL from TGenriched HDL 2 (27, 28) . HDL 2 may therefore stimulate HL by generating a novel substrate that catalyzes TG hydrolysis.
It is less clear how the smaller HDL particles may be acting to inhibit HL-mediated hydrolysis of VLDL. We had proposed that this inhibition may be due to the transfer of apoA-I from the HDL fraction to VLDL (15) It is now well established that efficient TG hydrolysis and clearance from the blood stream is directly related to the amount and kinds of HDL in the blood stream. This study may explain some of these poorly understood relationships between HDL and TG metabolism. The well described inverse relationship between HDL 2 and post prandial lipemia may in fact be a direct relationship and due to both an enhanced liberation of HL into the plasma compartment by this lipoprotein ( figure 7A ) and a direct stimulation of VLDL-TG hydrolysis (figure 7B).
Conversely, low HDL 2 and high levels of small HDL particles in the blood would be expected to reduce the displacement of cell surface HL and to directly inhibit the enzyme. This would link the low HDL 2 levels with high post heparin HL activity measurements and impaired VLDL hydrolysis and would be consistent with observations in numerous laboratories (29, 31, 32) . 
